Discovering Lupus Heterogeneity News Update May 22, 2019 Lupus is heterogeneous, meaning that symptoms are many and vary widely from patient to patient -- one...
LRA’s 2020 LMTA Grantees Focus on Finding Targets for New Lupus Drug Development Press Release NEW YORK, NY. December 3, 2020 - The Lupus Research Alliance is proud to announce the 2020 recipients of...
Hidroxicloroquina: fármaco típico para tratar el Lupus a prueba para el COVID-19 News Update 19 de marzo de 2020 En diciembre de 2019, se identificó un nuevo virus llamado SARS-COV-2 en Wuhan, China. Se...
Successful Advocacy Bringing Millions in Research Dollars to Lupus News Update June 28, 2018 With an overwhelming majority vote of 359 to 49, the House of Representatives just passed a bill...
Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation News Update NEW YORK, NY. March 14, 2019. The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today...
NIH Awards $500,000 to Advance to Advance Diversity in Lupus Trials News Update August 31, 2022 We are excited to share good news – our Lupus Clinical Investigators Network, LuCIN, managed by LRA’s...
2018 Distinguished Innovator Awardees Named by Lupus Research Alliance Press Release NEW YORK, NY. December 20. The Lupus Research Alliance is proud to announce the 2018 recipients of the Dr. William...
LRA’s 2019 Lupus Insight Prize Awarded to Dr. Ignacio Sanz Press Release Boston, MA. June 19, 2019. The Lupus Research Alliance has awarded its 2019 Lupus Insight Prize to Ignacio Sanz,...
2018 Lupus Insight Prize Presented to Dr. Betty Diamond Press Release 2018 Lupus Insight Prize Presented to Dr. Betty Diamond Funds Study of Common Hypertension Drugs to Treat Lupus June 21, 2018 The...
What do National Autoimmune Diseases Awareness and Women’s History Months have in Common? News Update March 10, 2021 It's no coincidence that March is designated as both National Autoimmune Diseases Awareness and Women’s History Months. ...
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Press Release February 21, 2018 Source: Press Release, National Institutes of Health NIH program to accelerate therapies for arthritis, lupus releases first datasets Collaborative...
End of Year Message from Lupus Research Alliance President & CEO Albert T. Roy Story 2025 has been an extraordinary year of momentum at the Lupus Research Alliance and clinical affiliate Lupus Therapeutics. Hear...